Ins ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has received IND clearance from FDA for ISM5939, a potential best-in-class ...
Elon Musk aims to transform X into an 'everything app,' expanding beyond social media to offer diverse services. This rebranding includes removing the iconic blue bird logo and adopting a streamlined ...